DEPLOYMENT · APAC
Bristol Myers Squibb expands AI and analytics footprint in India
Pharmaceutical major BMS is scaling its AI and data analytics operations in India, likely leveraging local talent and cost efficiency for drug discovery and clinical analytics.
WHY IT MATTERS
Pharma leaders moving AI capex to lower-cost geographies; signals trend of BFSI/enterprise R&D decoupling from high-cost centers, with implications for talent and regulatory oversight.
Source: Insurance Business · 2026-06-24